LYNNTECH INC. — Department of Defense SBIR Phase I: A18-145
LYNNTECH INC. — SBIR Phase I award from Department of Defense.
- Amount
- $149,882
- Agency
- Department of Defense · Army
- Program / Phase
- SBIR · Phase I
- Topic
- A18-145
- Solicitation
- 18.3
- NAICS
- —
- Place of performance
- TX
- Period
- 2019-05-20 → 2019-12-19
Description
Vascularized composite allotransplantation (VCA) is a surgical approach for the clinical management of non-salvagable injuries. Tissue rejection is a major issue for patients receiving VCA. Tacrolimus is the most common immunosuppressant employed to minim